Literature DB >> 26711739

Role of the Gut Microbiome in Obstructive Sleep Apnea-Induced Hypertension.

David J Durgan1, Bhanu P Ganesh2, Julia L Cope2, Nadim J Ajami2, Sharon C Phillips2, Joseph F Petrosino2, Emily B Hollister2, Robert M Bryan2.   

Abstract

Individuals suffering from obstructive sleep apnea (OSA) are at increased risk for systemic hypertension. The importance of a healthy gut microbiota, and detriment of a dysbiotic microbiota, on host physiology is becoming increasingly evident. We tested the hypothesis that gut dysbiosis contributes to hypertension observed with OSA. OSA was modeled in rats by inflating a tracheal balloon during the sleep cycle (10-s inflations, 60 per hour). On normal chow diet, OSA had no effect on blood pressure; however, in rats fed a high-fat diet, blood pressure increased 24 and 29 mm Hg after 7 and 14 days of OSA, respectively (P<0.05 each). Bacterial community characterization was performed on fecal pellets isolated before and after 14 days of OSA in chow and high-fat fed rats. High-fat diet and OSA led to significant alterations of the gut microbiota, including decreases in bacterial taxa known to produce the short chain fatty acid butyrate (P<0.05). Finally, transplant of dysbiotic cecal contents from hypertensive OSA rats on high-fat diet into OSA recipient rats on normal chow diet (shown to be normotensive) resulted in hypertension similar to that of the donor (increased 14 and 32 mm Hg after 7 and 14 days of OSA, respectively; P<0.05). These studies demonstrate a causal relationship between gut dysbiosis and hypertension, and suggest that manipulation of the microbiota may be a viable treatment for OSA-induced, and possibly other forms of, hypertension.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  butyrates; dysbiosis; hypertension; microbiota; obstructive sleep apnea

Mesh:

Year:  2015        PMID: 26711739      PMCID: PMC4713369          DOI: 10.1161/HYPERTENSIONAHA.115.06672

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  30 in total

1.  Gut dysbiosis is linked to hypertension.

Authors:  Tao Yang; Monica M Santisteban; Vermali Rodriguez; Eric Li; Niousha Ahmari; Jessica Marulanda Carvajal; Mojgan Zadeh; Minghao Gong; Yanfei Qi; Jasenka Zubcevic; Bikash Sahay; Carl J Pepine; Mohan K Raizada; Mansour Mohamadzadeh
Journal:  Hypertension       Date:  2015-04-13       Impact factor: 10.190

Review 2.  Sleep apnea and cardiovascular disease: a bidirectional relationship.

Authors:  Takatoshi Kasai; John S Floras; T Douglas Bradley
Journal:  Circulation       Date:  2012-09-18       Impact factor: 29.690

3.  Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension.

Authors:  Rodrigo P Pedrosa; Luciano F Drager; Carolina C Gonzaga; Marcio G Sousa; Lílian K G de Paula; Aline C S Amaro; Celso Amodeo; Luiz A Bortolotto; Eduardo M Krieger; T Douglas Bradley; Geraldo Lorenzi-Filho
Journal:  Hypertension       Date:  2011-10-03       Impact factor: 10.190

4.  Plasma lactate and incident hypertension in the atherosclerosis risk in communities study.

Authors:  Stephen P Juraschek; Julie K Bower; Elizabeth Selvin; Ghanshyam Palamaner Subash Shantha; Ron C Hoogeveen; Christie M Ballantyne; J Hunter Young
Journal:  Am J Hypertens       Date:  2014-07-03       Impact factor: 2.689

5.  Pathological effects of obstructive apneas during the sleep cycle in an animal model of cerebral small vessel disease.

Authors:  Eric E Lloyd; David J Durgan; Sharyl R Martini; Robert M Bryan
Journal:  Hypertension       Date:  2015-08-10       Impact factor: 10.190

Review 6.  Diabetes, obesity and gut microbiota.

Authors:  Amandine Everard; Patrice D Cani
Journal:  Best Pract Res Clin Gastroenterol       Date:  2013-02       Impact factor: 3.043

7.  Enteric neurones modulate the colonic permeability response to luminal bile acids in rat colon in vivo.

Authors:  Y Sun; B-M Fihn; H Sjövall; M Jodal
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

8.  The epigenetic effects of butyrate: potential therapeutic implications for clinical practice.

Authors:  Roberto Berni Canani; Margherita Di Costanzo; Ludovica Leone
Journal:  Clin Epigenetics       Date:  2012-02-27       Impact factor: 6.551

Review 9.  Dysbiotic events in gut microbiota: impact on human health.

Authors:  Serena Schippa; Maria Pia Conte
Journal:  Nutrients       Date:  2014-12-11       Impact factor: 5.717

10.  Cerebrovascular consequences of obstructive sleep apnea.

Authors:  David J Durgan; Robert M Bryan
Journal:  J Am Heart Assoc       Date:  2012-08-24       Impact factor: 5.501

View more
  115 in total

Review 1.  From obesity through gut microbiota to cardiovascular diseases: a dangerous journey.

Authors:  Paolo Marzullo; Laura Di Renzo; Gabriella Pugliese; Martina De Siena; Luigi Barrea; Giovanna Muscogiuri; Annamaria Colao; Silvia Savastano
Journal:  Int J Obes Suppl       Date:  2020-07-20

Review 2.  Microbial modulation of cardiovascular disease.

Authors:  J Mark Brown; Stanley L Hazen
Journal:  Nat Rev Microbiol       Date:  2018-01-08       Impact factor: 60.633

Review 3.  Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery.

Authors:  J Mark Brown; Stanley L Hazen
Journal:  J Biol Chem       Date:  2017-04-07       Impact factor: 5.157

4.  Pediatric Obstructive Sleep Apnea is Associated With Changes in the Oral Microbiome and Urinary Metabolomics Profile: A Pilot Study.

Authors:  Huajun Xu; Xiaoyan Li; Xiaojiao Zheng; Yunyan Xia; Yiqun Fu; Xinyi Li; Yingjun Qian; Jianyin Zou; Aihua Zhao; Jian Guan; Meizhen Gu; Hongliang Yi; Wei Jia; Shankai Yin
Journal:  J Clin Sleep Med       Date:  2018-09-15       Impact factor: 4.062

Review 5.  Antihypertensive Effects of Probiotics.

Authors:  Iñaki Robles-Vera; Marta Toral; Miguel Romero; Rosario Jiménez; Manuel Sánchez; Francisco Pérez-Vizcaíno; Juan Duarte
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

Review 6.  Microbial Short-Chain Fatty Acids and Blood Pressure Regulation.

Authors:  Jennifer L Pluznick
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

7.  Temporal and region-specific effects of sleep fragmentation on gut microbiota and intestinal morphology in Sprague Dawley rats.

Authors:  Judy Triplett; David Ellis; Amber Braddock; Erin Roberts; Katherine Ingram; Eric Perez; Amanda Short; Dominique Brown; Victoria Hutzley; Chelsey Webb; Armando Soto; Victor Chan
Journal:  Gut Microbes       Date:  2020-01-10

Review 8.  Gastrointestinal Tract: a Promising Target for the Management of Hypertension.

Authors:  Shiqiang Xiong; Qiang Li; Daoyan Liu; Zhiming Zhu
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

Review 9.  The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.

Authors:  Mehmet Kanbay; Emine M Onal; Baris Afsar; Tuncay Dagel; Aslihan Yerlikaya; Adrian Covic; Nosratola D Vaziri
Journal:  Int Urol Nephrol       Date:  2018-05-04       Impact factor: 2.370

10.  Prebiotics, Probiotics, and Acetate Supplementation Prevent Hypertension in a Model of Obstructive Sleep Apnea.

Authors:  Bhanu P Ganesh; James W Nelson; Joshua R Eskew; Arunkumar Ganesan; Nadim J Ajami; Joseph F Petrosino; Robert M Bryan; David J Durgan
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.